| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | snoRNA binding | 8.25e-07 | 34 | 43 | 4 | GO:0030515 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 6.87e-05 | 37 | 43 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.56e-04 | 739 | 43 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.40e-04 | 262 | 43 | 5 | GO:0140097 | |
| GeneOntologyMolecularFunction | helicase activity | 3.66e-04 | 158 | 43 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 4.16e-04 | 645 | 43 | 7 | GO:0140640 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 7.58e-04 | 83 | 43 | 3 | GO:1990841 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.05e-03 | 93 | 43 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.91e-03 | 614 | 43 | 6 | GO:0140657 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.48e-03 | 441 | 43 | 5 | GO:0016887 | |
| GeneOntologyMolecularFunction | histone binding | 2.49e-03 | 265 | 43 | 4 | GO:0042393 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.58e-03 | 127 | 43 | 3 | GO:0008094 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 1.96e-10 | 275 | 43 | 10 | GO:0016072 | |
| GeneOntologyBiologicalProcess | transcription by RNA polymerase I | 6.23e-07 | 79 | 43 | 5 | GO:0006360 | |
| GeneOntologyBiologicalProcess | rRNA transcription | 2.51e-06 | 46 | 43 | 4 | GO:0009303 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 4.49e-06 | 999 | 43 | 11 | GO:0071824 | |
| GeneOntologyBiologicalProcess | ribosome biogenesis | 5.57e-06 | 336 | 43 | 7 | GO:0042254 | |
| GeneOntologyBiologicalProcess | rRNA processing | 7.78e-06 | 230 | 43 | 6 | GO:0006364 | |
| GeneOntologyBiologicalProcess | chromatin organization | 1.18e-05 | 896 | 43 | 10 | GO:0006325 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 1.79e-05 | 741 | 43 | 9 | GO:0006338 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | 2.10e-05 | 574 | 43 | 8 | GO:0010638 | |
| GeneOntologyBiologicalProcess | nucleolar large rRNA transcription by RNA polymerase I | 2.12e-05 | 26 | 43 | 3 | GO:0042790 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase I | 6.24e-05 | 37 | 43 | 3 | GO:0045943 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 8.59e-05 | 515 | 43 | 7 | GO:0022613 | |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase I | 1.51e-04 | 9 | 43 | 2 | GO:0006362 | |
| GeneOntologyBiologicalProcess | regulation of transcription by RNA polymerase I | 1.54e-04 | 50 | 43 | 3 | GO:0006356 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic plasticity | 3.80e-04 | 14 | 43 | 2 | GO:0031915 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance in response to DNA damage | 4.38e-04 | 15 | 43 | 2 | GO:1904507 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance | 4.55e-04 | 72 | 43 | 3 | GO:0032206 | |
| GeneOntologyBiologicalProcess | regulation of DNA strand elongation | 5.66e-04 | 17 | 43 | 2 | GO:0060382 | |
| GeneOntologyCellularComponent | fibrillar center | 1.86e-05 | 156 | 44 | 5 | GO:0001650 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 4.92e-05 | 96 | 44 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | nuclear body | 9.13e-05 | 903 | 44 | 9 | GO:0016604 | |
| GeneOntologyCellularComponent | ATPase complex | 1.55e-04 | 129 | 44 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 4.69e-04 | 1377 | 44 | 10 | GO:0140513 | |
| GeneOntologyCellularComponent | Ino80 complex | 5.77e-04 | 17 | 44 | 2 | GO:0031011 | |
| GeneOntologyCellularComponent | Cajal body | 7.36e-04 | 84 | 44 | 3 | GO:0015030 | |
| GeneOntologyCellularComponent | chromatin | 8.25e-04 | 1480 | 44 | 10 | GO:0000785 | |
| GeneOntologyCellularComponent | INO80-type complex | 1.58e-03 | 28 | 44 | 2 | GO:0097346 | |
| GeneOntologyCellularComponent | sno(s)RNA-containing ribonucleoprotein complex | 2.06e-03 | 32 | 44 | 2 | GO:0005732 | |
| MousePheno | abnormal inner ear vestibule morphology | 1.63e-06 | 81 | 35 | 5 | MP:0000034 | |
| MousePheno | absent nasal pit | 1.82e-05 | 3 | 35 | 2 | MP:0030060 | |
| MousePheno | bidirectional circling | 2.81e-05 | 24 | 35 | 3 | MP:0001395 | |
| MousePheno | abnormal cranial ganglia morphology | 6.95e-05 | 175 | 35 | 5 | MP:0001081 | |
| MousePheno | abnormal inner ear morphology | 9.43e-05 | 303 | 35 | 6 | MP:0000026 | |
| MousePheno | abnormal head movements | 1.22e-04 | 103 | 35 | 4 | MP:0000436 | |
| MousePheno | abnormal ear morphology | 1.38e-04 | 470 | 35 | 7 | MP:0002102 | |
| MousePheno | head tilt | 1.77e-04 | 44 | 35 | 3 | MP:0005191 | |
| MousePheno | abnormal sensory ganglion morphology | 2.08e-04 | 221 | 35 | 5 | MP:0000960 | |
| MousePheno | abnormal nasal pit morphology | 2.17e-04 | 9 | 35 | 2 | MP:0006306 | |
| MousePheno | abnormal cingulate gyrus morphology | 2.71e-04 | 10 | 35 | 2 | MP:0004167 | |
| MousePheno | head bobbing | 2.76e-04 | 51 | 35 | 3 | MP:0001410 | |
| MousePheno | hearing/vestibular/ear phenotype | 2.93e-04 | 905 | 35 | 9 | MP:0005377 | |
| MousePheno | abnormal crista ampullaris neuroepithelium morphology | 3.30e-04 | 11 | 35 | 2 | MP:0004409 | |
| MousePheno | abnormal cingulate cortex morphology | 4.67e-04 | 13 | 35 | 2 | MP:0020749 | |
| MousePheno | tachypnea | 4.67e-04 | 13 | 35 | 2 | MP:0005426 | |
| MousePheno | abnormal stationary movement | 4.77e-04 | 147 | 35 | 4 | MP:0001388 | |
| MousePheno | cochlear ganglion degeneration | 5.15e-04 | 63 | 35 | 3 | MP:0002857 | |
| MousePheno | small first pharyngeal arch | 5.44e-04 | 14 | 35 | 2 | MP:0006341 | |
| MousePheno | small otic vesicle | 6.27e-04 | 15 | 35 | 2 | MP:0004310 | |
| Domain | Helicase_C | 5.11e-06 | 107 | 44 | 5 | PF00271 | |
| Domain | HELICc | 5.11e-06 | 107 | 44 | 5 | SM00490 | |
| Domain | Helicase_C | 5.35e-06 | 108 | 44 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 5.59e-06 | 109 | 44 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.59e-06 | 109 | 44 | 5 | PS51192 | |
| Domain | DEXDc | 5.59e-06 | 109 | 44 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.85e-06 | 110 | 44 | 5 | IPR014001 | |
| Domain | - | 8.37e-06 | 55 | 44 | 4 | 1.10.30.10 | |
| Domain | HMG_box_dom | 1.63e-05 | 65 | 44 | 4 | IPR009071 | |
| Domain | SNF2_N | 5.77e-05 | 32 | 44 | 3 | PF00176 | |
| Domain | SNF2_N | 5.77e-05 | 32 | 44 | 3 | IPR000330 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 7.57e-05 | 35 | 44 | 3 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 9.71e-05 | 38 | 44 | 3 | PS00690 | |
| Domain | HMG_box_2 | 1.93e-04 | 9 | 44 | 2 | PF09011 | |
| Domain | HMG_box | 2.63e-04 | 53 | 44 | 3 | PF00505 | |
| Domain | HMG_BOX_2 | 2.78e-04 | 54 | 44 | 3 | PS50118 | |
| Domain | HMG | 2.78e-04 | 54 | 44 | 3 | SM00398 | |
| Domain | Zinc_finger_PHD-type_CS | 4.81e-04 | 65 | 44 | 3 | IPR019786 | |
| Domain | PHD | 7.32e-04 | 75 | 44 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 8.51e-04 | 79 | 44 | 3 | IPR019787 | |
| Domain | PHD | 1.20e-03 | 89 | 44 | 3 | SM00249 | |
| Domain | Znf_PHD | 1.28e-03 | 91 | 44 | 3 | IPR001965 | |
| Domain | Chromo_domain | 1.45e-03 | 24 | 44 | 2 | IPR023780 | |
| Domain | ZF_PHD_2 | 1.45e-03 | 95 | 44 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 1.50e-03 | 96 | 44 | 3 | PS01359 | |
| Domain | Chromo | 1.70e-03 | 26 | 44 | 2 | PF00385 | |
| Domain | AT_hook | 1.83e-03 | 27 | 44 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.83e-03 | 27 | 44 | 2 | IPR017956 | |
| Domain | CHROMO_2 | 1.97e-03 | 28 | 44 | 2 | PS50013 | |
| Domain | CHROMO_1 | 1.97e-03 | 28 | 44 | 2 | PS00598 | |
| Domain | HMGI/Y_DNA-bd_CS | 2.42e-03 | 31 | 44 | 2 | IPR000637 | |
| Domain | Ion_trans_dom | 2.44e-03 | 114 | 44 | 3 | IPR005821 | |
| Domain | Ion_trans | 2.44e-03 | 114 | 44 | 3 | PF00520 | |
| Domain | Chromodomain-like | 2.57e-03 | 32 | 44 | 2 | IPR016197 | |
| Domain | CHROMO | 2.73e-03 | 33 | 44 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 2.73e-03 | 33 | 44 | 2 | IPR000953 | |
| Pathway | WP_ECTODERM_DIFFERENTIATION | 2.51e-04 | 142 | 31 | 4 | M39575 | |
| Pathway | REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL | 3.03e-04 | 60 | 31 | 3 | M27613 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NELFE POLR1F DKC1 RAD51AP1 PUM3 NOP58 ZNF609 CHD7 ILF3 BBX RRBP1 UBN1 MAP1B DDX21 MECP2 TOP1 UBTF KTN1 WBP4 NFRKB | 4.52e-20 | 954 | 44 | 20 | 36373674 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | NELFE POLR1F DKC1 AKAP13 NOP58 ZNF609 INO80 ILF3 RRBP1 EIF2A MAP1B FERMT2 DDX21 TOP1 DHX37 KTN1 | 2.56e-16 | 724 | 44 | 16 | 36232890 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DKC1 NOP58 ZNF609 CHD7 INO80 ILF3 BBX PHF8 PHF20 RRBP1 UBN1 DDX21 TCOF1 MECP2 TOP1 UBTF FRG1 KTN1 NFRKB | 3.55e-16 | 1294 | 44 | 19 | 30804502 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RAD51AP1 PUM3 NOP58 CHD7 INO80 BBX PHF8 UBN1 MECP2 TOP1 UBTF DHX37 FRG1 CHD5 NFRKB | 5.29e-16 | 608 | 44 | 15 | 36089195 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | POLR1F DKC1 PUM3 AKAP13 NOP58 CHD7 ILF3 PHF8 RRBP1 UBN1 EIF2A MAP1B FERMT2 DDX21 TOP1 UBTF DHX37 AP3D1 KTN1 | 7.99e-16 | 1353 | 44 | 19 | 29467282 |
| Pubmed | NELFE DKC1 PUM3 NOP58 TRPM1 CHD7 ILF3 RRBP1 DDX21 TCOF1 MECP2 TOP1 DHX37 AP3D1 RALBP1 FRG1 KTN1 | 3.04e-13 | 1371 | 44 | 17 | 36244648 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | POLR1F DKC1 PUM3 NOP58 PHF8 RRBP1 MAP1B DDX21 TOP1 UBTF DHX37 AP3D1 FRG1 KTN1 | 3.10e-13 | 759 | 44 | 14 | 35915203 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DKC1 NOP58 CHD7 INO80 ILF3 BBX MAP1B DDX21 TCOF1 MECP2 TOP1 DHX37 AP3D1 FRG1 | 3.53e-11 | 1082 | 44 | 14 | 38697112 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NELFE DKC1 ILF3 RRBP1 EIF2A MAP1B FERMT2 DDX21 TCOF1 TOP1 UBTF AP3D1 KTN1 | 8.36e-11 | 934 | 44 | 13 | 33916271 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 4.20e-10 | 486 | 44 | 10 | 30940648 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RABL6 POLR1F DKC1 NOP58 CHD7 ILF3 RRBP1 DDX21 TCOF1 TOP1 DHX37 AP3D1 FRG1 NFRKB | 4.66e-10 | 1318 | 44 | 14 | 30463901 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.02e-09 | 533 | 44 | 10 | 30554943 | |
| Pubmed | DKC1 RAD51AP1 ILF3 BBX RRBP1 LRRC43 MAP1B DDX21 MECP2 TOP1 AP3D1 CHD5 FER1L6 KTN1 | 1.49e-09 | 1442 | 44 | 14 | 35575683 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DKC1 NOP58 ILF3 RRBP1 DDX21 TCOF1 TOP1 UBTF DHX37 AP3D1 FRG1 CHD5 | 1.50e-09 | 949 | 44 | 12 | 36574265 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.98e-09 | 410 | 44 | 9 | 26949251 | |
| Pubmed | 2.10e-09 | 172 | 44 | 7 | 26336360 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NELFE POLR1F DKC1 PUM3 NOP58 ILF3 DDX21 TCOF1 TOP1 UBTF DHX37 FRG1 | 2.39e-09 | 989 | 44 | 12 | 36424410 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NELFE DKC1 CHD7 ILF3 PHF8 RRBP1 UBN1 DDX21 TCOF1 MECP2 NFRKB | 2.43e-09 | 774 | 44 | 11 | 15302935 |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 2.45e-09 | 96 | 44 | 6 | 25948554 | |
| Pubmed | NELFE POLR1F DKC1 NOP58 INO80 ILF3 PHF8 RRBP1 UBN1 EIF2A TOP1 UBTF | 3.16e-09 | 1014 | 44 | 12 | 32416067 | |
| Pubmed | 3.75e-09 | 103 | 44 | 6 | 32744500 | ||
| Pubmed | 4.02e-09 | 615 | 44 | 10 | 31048545 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 4.75e-09 | 626 | 44 | 10 | 33644029 | |
| Pubmed | 6.17e-09 | 847 | 44 | 11 | 35850772 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 7.95e-09 | 330 | 44 | 8 | 33301849 | |
| Pubmed | NELFE PUM3 NOP58 ZNF609 CHD7 ILF3 EIF2A MECP2 TOP1 UBTF FRG1 NFRKB | 8.06e-09 | 1103 | 44 | 12 | 34189442 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NELFE DKC1 AKAP13 NOP58 ILF3 RRBP1 EIF2A DDX21 TCOF1 TOP1 AP3D1 FRG1 KTN1 | 1.27e-08 | 1415 | 44 | 13 | 28515276 |
| Pubmed | 1.53e-08 | 708 | 44 | 10 | 39231216 | ||
| Pubmed | 3.37e-08 | 72 | 44 | 5 | 12777385 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PUM3 NOP58 ILF3 RRBP1 EIF2A DDX21 MECP2 TOP1 UBTF DHX37 FRG1 CHD5 | 3.41e-08 | 1257 | 44 | 12 | 36526897 |
| Pubmed | 5.04e-08 | 419 | 44 | 8 | 15635413 | ||
| Pubmed | 5.08e-08 | 159 | 44 | 6 | 22751105 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 5.67e-08 | 605 | 44 | 9 | 28977666 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 6.14e-08 | 430 | 44 | 8 | 38172120 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 6.50e-08 | 283 | 44 | 7 | 30585729 | |
| Pubmed | 9.66e-08 | 300 | 44 | 7 | 28561026 | ||
| Pubmed | 1.08e-07 | 653 | 44 | 9 | 22586326 | ||
| Pubmed | 1.19e-07 | 469 | 44 | 8 | 37314180 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.37e-07 | 316 | 44 | 7 | 31665637 | |
| Pubmed | PUM3 ZNF609 CHD7 INO80 BBX PHF8 UBN1 TOP1 UBTF DHX37 CHD5 NFRKB | 1.37e-07 | 1429 | 44 | 12 | 35140242 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 1.40e-07 | 317 | 44 | 7 | 17620599 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.81e-07 | 197 | 44 | 6 | 20811636 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.97e-07 | 701 | 44 | 9 | 30196744 | |
| Pubmed | 2.21e-07 | 339 | 44 | 7 | 30415952 | ||
| Pubmed | 2.27e-07 | 713 | 44 | 9 | 29802200 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.30e-07 | 341 | 44 | 7 | 32971831 | |
| Pubmed | 2.55e-07 | 723 | 44 | 9 | 34133714 | ||
| Pubmed | 2.61e-07 | 725 | 44 | 9 | 27025967 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 2.69e-07 | 349 | 44 | 7 | 25665578 | |
| Pubmed | 2.88e-07 | 971 | 44 | 10 | 33306668 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 4.68e-07 | 1024 | 44 | 10 | 24711643 | |
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 5.77e-07 | 52 | 44 | 4 | 24591637 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 6.06e-07 | 394 | 44 | 7 | 27248496 | |
| Pubmed | 6.27e-07 | 396 | 44 | 7 | 26687479 | ||
| Pubmed | 6.48e-07 | 245 | 44 | 6 | 21182205 | ||
| Pubmed | 6.52e-07 | 809 | 44 | 9 | 32129710 | ||
| Pubmed | Cell-fate determination by ubiquitin-dependent regulation of translation. | 6.81e-07 | 14 | 44 | 3 | 26399832 | |
| Pubmed | 7.78e-07 | 601 | 44 | 8 | 33658012 | ||
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 7.80e-07 | 56 | 44 | 4 | 26919559 | |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | 8.07e-07 | 604 | 44 | 8 | 37616343 | |
| Pubmed | 9.17e-07 | 260 | 44 | 6 | 36199071 | ||
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 1.12e-06 | 269 | 44 | 6 | 29511261 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.16e-06 | 1425 | 44 | 11 | 30948266 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.17e-06 | 271 | 44 | 6 | 32433965 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.24e-06 | 148 | 44 | 5 | 32538781 | |
| Pubmed | 1.26e-06 | 641 | 44 | 8 | 36057605 | ||
| Pubmed | 1.37e-06 | 1153 | 44 | 10 | 29845934 | ||
| Pubmed | 1.45e-06 | 653 | 44 | 8 | 33742100 | ||
| Pubmed | 1.48e-06 | 655 | 44 | 8 | 35819319 | ||
| Pubmed | The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically. | 1.52e-06 | 66 | 44 | 4 | 32051553 | |
| Pubmed | Treacle recruits RNA polymerase I complex to the nucleolus that is independent of UBF. | 1.56e-06 | 2 | 44 | 2 | 19527688 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 15249688 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 10679015 | ||
| Pubmed | 1.61e-06 | 156 | 44 | 5 | 22952844 | ||
| Pubmed | AKAP13 NOP58 ILF3 RRBP1 EIF2A FERMT2 DDX21 TCOF1 UBTF AP3D1 KTN1 | 1.75e-06 | 1487 | 44 | 11 | 33957083 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 1.91e-06 | 678 | 44 | 8 | 30209976 | |
| Pubmed | 1.93e-06 | 469 | 44 | 7 | 27634302 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.10e-06 | 475 | 44 | 7 | 31040226 | |
| Pubmed | 2.34e-06 | 483 | 44 | 7 | 36912080 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 2.52e-06 | 704 | 44 | 8 | 29955894 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 2.80e-06 | 714 | 44 | 8 | 28302793 | |
| Pubmed | 2.88e-06 | 317 | 44 | 6 | 30997501 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 3.10e-06 | 321 | 44 | 6 | 32098917 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 3.87e-06 | 1005 | 44 | 9 | 19615732 | |
| Pubmed | 4.31e-06 | 340 | 44 | 6 | 29478914 | ||
| Pubmed | Systematic characterization of deubiquitylating enzymes for roles in maintaining genome integrity. | 4.69e-06 | 3 | 44 | 2 | 25194926 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 22679391 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 21111237 | ||
| Pubmed | 4.79e-06 | 195 | 44 | 5 | 19454010 | ||
| Pubmed | 4.80e-06 | 1327 | 44 | 10 | 32694731 | ||
| Pubmed | 5.30e-06 | 547 | 44 | 7 | 37267103 | ||
| Pubmed | 5.43e-06 | 549 | 44 | 7 | 38280479 | ||
| Pubmed | 5.67e-06 | 786 | 44 | 8 | 29128334 | ||
| Pubmed | 6.55e-06 | 208 | 44 | 5 | 11790298 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 6.87e-06 | 807 | 44 | 8 | 22681889 | |
| Pubmed | 6.93e-06 | 808 | 44 | 8 | 20412781 | ||
| Pubmed | 7.69e-06 | 215 | 44 | 5 | 30462309 | ||
| Pubmed | 8.65e-06 | 102 | 44 | 4 | 26584622 | ||
| Pubmed | 9.00e-06 | 1116 | 44 | 9 | 31753913 | ||
| Pubmed | Proteomic analysis of complexes formed by human topoisomerase I. | 9.13e-06 | 32 | 44 | 3 | 15848144 | |
| Interaction | SMC5 interactions | NELFE POLR1F DKC1 RAD51AP1 PUM3 NOP58 ZNF609 CHD7 ILF3 BBX RRBP1 UBN1 MAP1B DDX21 MECP2 TOP1 UBTF KTN1 WBP4 NFRKB | 3.85e-15 | 1000 | 44 | 20 | int:SMC5 |
| Interaction | ZNF330 interactions | DKC1 RAD51AP1 PUM3 NOP58 CHD7 ILF3 BBX PHF8 DDX21 MECP2 TOP1 UBTF DHX37 FRG1 | 3.46e-13 | 446 | 44 | 14 | int:ZNF330 |
| Interaction | H3-3A interactions | KCNQ1 RAD51AP1 PUM3 CHD7 INO80 BBX PHF8 UBN1 MECP2 TOP1 UBTF DHX37 RALBP1 FRG1 CHD5 NFRKB | 1.78e-12 | 749 | 44 | 16 | int:H3-3A |
| Interaction | MYCN interactions | DKC1 PUM3 AKAP13 NOP58 ZNF609 CHD7 ILF3 BBX EIF2A MAP1B DDX21 TCOF1 MECP2 TOP1 UBTF DHX37 FRG1 KTN1 WBP4 | 1.64e-11 | 1373 | 44 | 19 | int:MYCN |
| Interaction | MEN1 interactions | NELFE DKC1 PUM3 NOP58 ZNF609 INO80 ILF3 PHF8 PHF20 DDX21 TCOF1 TOP1 UBTF DHX37 AP3D1 FRG1 KTN1 | 1.78e-11 | 1029 | 44 | 17 | int:MEN1 |
| Interaction | POLR1G interactions | POLR1F DKC1 PUM3 NOP58 CHD7 BBX PHF8 DDX21 TCOF1 MECP2 TOP1 UBTF DHX37 | 2.26e-11 | 489 | 44 | 13 | int:POLR1G |
| Interaction | H3C3 interactions | PUM3 NOP58 CHD7 BBX PHF8 MECP2 TOP1 UBTF DHX37 FRG1 CHD5 NFRKB | 4.36e-10 | 495 | 44 | 12 | int:H3C3 |
| Interaction | SNRNP40 interactions | DKC1 NOP58 ZNF609 ILF3 PHF8 UBN1 DDX21 TCOF1 MECP2 TOP1 UBTF WBP4 NFRKB | 5.87e-10 | 637 | 44 | 13 | int:SNRNP40 |
| Interaction | RPL31 interactions | DKC1 PUM3 NOP58 ILF3 BBX PHF8 RRBP1 DDX21 TCOF1 TOP1 UBTF DHX37 FRG1 | 1.30e-09 | 680 | 44 | 13 | int:RPL31 |
| Interaction | NIFK interactions | 1.53e-09 | 431 | 44 | 11 | int:NIFK | |
| Interaction | DDX23 interactions | 4.71e-09 | 480 | 44 | 11 | int:DDX23 | |
| Interaction | NUP43 interactions | DKC1 NOP58 ZNF609 INO80 BBX PHF8 EIF2A MECP2 TOP1 UBTF FRG1 NFRKB | 6.06e-09 | 625 | 44 | 12 | int:NUP43 |
| Interaction | MKI67 interactions | POLR1F PUM3 AKAP13 NOP58 CHD7 BBX RRBP1 MAP1B TCOF1 MECP2 TOP1 FRG1 | 9.07e-09 | 648 | 44 | 12 | int:MKI67 |
| Interaction | NAA40 interactions | NELFE DKC1 ILF3 RRBP1 EIF2A MAP1B FERMT2 DDX21 TCOF1 MECP2 TOP1 UBTF AP3D1 KTN1 | 1.08e-08 | 978 | 44 | 14 | int:NAA40 |
| Interaction | HECTD1 interactions | POLR1F DKC1 PUM3 NOP58 PHF8 RRBP1 MAP1B DDX21 TOP1 UBTF DHX37 AP3D1 FRG1 KTN1 | 1.16e-08 | 984 | 44 | 14 | int:HECTD1 |
| Interaction | COIL interactions | 1.99e-08 | 552 | 44 | 11 | int:COIL | |
| Interaction | NOP56 interactions | 2.77e-08 | 570 | 44 | 11 | int:NOP56 | |
| Interaction | POU5F1 interactions | NOP58 TRPM1 CHD7 INO80 ILF3 TCOF1 TOP1 AP3D1 FRG1 CHD5 NFRKB | 3.55e-08 | 584 | 44 | 11 | int:POU5F1 |
| Interaction | H3C1 interactions | DKC1 CHD7 BBX PHF8 PHF20 RRBP1 UBN1 MECP2 TOP1 UBTF DHX37 RALBP1 FRG1 | 3.74e-08 | 901 | 44 | 13 | int:H3C1 |
| Interaction | PARP1 interactions | RABL6 DKC1 RAD51AP1 NOP58 CHD7 ILF3 BBX PHF8 FERMT2 DDX21 MECP2 TOP1 UBTF DHX37 AP3D1 | 5.87e-08 | 1316 | 44 | 15 | int:PARP1 |
| Interaction | CHD4 interactions | NELFE RABL6 DKC1 PUM3 NOP58 ILF3 RRBP1 DDX21 TCOF1 MECP2 TOP1 UBTF CHD5 | 6.00e-08 | 938 | 44 | 13 | int:CHD4 |
| Interaction | FGFBP1 interactions | 7.48e-08 | 257 | 44 | 8 | int:FGFBP1 | |
| Interaction | PES1 interactions | 7.70e-08 | 258 | 44 | 8 | int:PES1 | |
| Interaction | BRD7 interactions | 8.57e-08 | 637 | 44 | 11 | int:BRD7 | |
| Interaction | FBL interactions | DKC1 PUM3 NOP58 RRBP1 DDX21 TCOF1 MECP2 TOP1 UBTF DHX37 KTN1 | 8.84e-08 | 639 | 44 | 11 | int:FBL |
| Interaction | SNRNP70 interactions | NELFE RABL6 DKC1 NOP58 ILF3 BBX EIF2A MAP1B DDX21 MECP2 TOP1 FRG1 WBP4 | 1.05e-07 | 984 | 44 | 13 | int:SNRNP70 |
| Interaction | RPL11 interactions | DKC1 PUM3 NOP58 CHD7 ILF3 RRBP1 MAP1B DDX21 TCOF1 MECP2 KTN1 | 1.08e-07 | 652 | 44 | 11 | int:RPL11 |
| Interaction | H1-4 interactions | 1.15e-07 | 656 | 44 | 11 | int:H1-4 | |
| Interaction | NR2C2 interactions | RABL6 POLR1F DKC1 NOP58 CHD7 ILF3 RRBP1 UBN1 DDX21 TCOF1 TOP1 DHX37 AP3D1 FRG1 NFRKB | 1.36e-07 | 1403 | 44 | 15 | int:NR2C2 |
| Interaction | RBBP5 interactions | 1.74e-07 | 287 | 44 | 8 | int:RBBP5 | |
| Interaction | EFTUD2 interactions | NELFE DKC1 AKAP13 NOP58 ILF3 RRBP1 EIF2A DDX21 TCOF1 MECP2 TOP1 AP3D1 FRG1 KTN1 WBP4 | 2.07e-07 | 1449 | 44 | 15 | int:EFTUD2 |
| Interaction | SCARNA22 interactions | 2.09e-07 | 118 | 44 | 6 | int:SCARNA22 | |
| Interaction | KCNA3 interactions | RABL6 TRPM1 ILF3 RRBP1 EIF2A MAP1B FERMT2 TCOF1 TOP1 UBTF AP3D1 KTN1 | 2.31e-07 | 871 | 44 | 12 | int:KCNA3 |
| Interaction | RPS6 interactions | DKC1 PUM3 NOP58 ILF3 BBX RRBP1 EIF2A DDX21 MECP2 TOP1 UBTF DHX37 | 2.40e-07 | 874 | 44 | 12 | int:RPS6 |
| Interaction | MECP2 interactions | DKC1 NOP58 CHD7 INO80 ILF3 BBX MAP1B DDX21 TCOF1 MECP2 TOP1 DHX37 AP3D1 FRG1 | 3.28e-07 | 1287 | 44 | 14 | int:MECP2 |
| Interaction | MACROH2A2 interactions | 3.44e-07 | 211 | 44 | 7 | int:MACROH2A2 | |
| Interaction | ZBTB2 interactions | 4.51e-07 | 450 | 44 | 9 | int:ZBTB2 | |
| Interaction | TERF2 interactions | 6.31e-07 | 340 | 44 | 8 | int:TERF2 | |
| Interaction | TAF1A interactions | 7.36e-07 | 78 | 44 | 5 | int:TAF1A | |
| Interaction | MAGEB2 interactions | 7.68e-07 | 349 | 44 | 8 | int:MAGEB2 | |
| Interaction | POLR1E interactions | 7.85e-07 | 350 | 44 | 8 | int:POLR1E | |
| Interaction | DLST interactions | 9.18e-07 | 490 | 44 | 9 | int:DLST | |
| Interaction | CBX3 interactions | 9.90e-07 | 646 | 44 | 10 | int:CBX3 | |
| Interaction | SUB1 interactions | 9.93e-07 | 247 | 44 | 7 | int:SUB1 | |
| Interaction | TNIP1 interactions | DKC1 NOP58 ILF3 RRBP1 DDX21 TCOF1 TOP1 UBTF DHX37 AP3D1 RALBP1 FRG1 CHD5 | 1.19e-06 | 1217 | 44 | 13 | int:TNIP1 |
| Interaction | CENPA interactions | 1.37e-06 | 377 | 44 | 8 | int:CENPA | |
| Interaction | PSPC1 interactions | 1.39e-06 | 515 | 44 | 9 | int:PSPC1 | |
| Interaction | DDRGK1 interactions | DKC1 PUM3 NOP58 ILF3 PHF8 RRBP1 DDX21 TCOF1 TOP1 UBTF DHX37 AP3D1 FRG1 | 1.59e-06 | 1249 | 44 | 13 | int:DDRGK1 |
| Interaction | RPS24 interactions | 1.73e-06 | 529 | 44 | 9 | int:RPS24 | |
| Interaction | APEX1 interactions | DKC1 NOP58 CHD7 INO80 BBX PHF8 ZNF236 EIF2A FERMT2 TCOF1 MECP2 UBTF KTN1 | 1.94e-06 | 1271 | 44 | 13 | int:APEX1 |
| Interaction | IFI16 interactions | 2.44e-06 | 714 | 44 | 10 | int:IFI16 | |
| Interaction | RPS16 interactions | 2.76e-06 | 724 | 44 | 10 | int:RPS16 | |
| Interaction | TCOF1 interactions | 3.02e-06 | 292 | 44 | 7 | int:TCOF1 | |
| Interaction | LARP7 interactions | DKC1 PUM3 NOP58 CHD7 ILF3 PHF8 DDX21 TCOF1 TOP1 UBTF DHX37 FRG1 | 3.09e-06 | 1113 | 44 | 12 | int:LARP7 |
| Interaction | H2BC8 interactions | 3.47e-06 | 576 | 44 | 9 | int:H2BC8 | |
| Interaction | RPL4 interactions | 4.45e-06 | 764 | 44 | 10 | int:RPL4 | |
| Interaction | LRRC43 interactions | 4.66e-06 | 2 | 44 | 2 | int:LRRC43 | |
| Interaction | RPL5 interactions | 5.24e-06 | 606 | 44 | 9 | int:RPL5 | |
| Interaction | WDR36 interactions | 5.72e-06 | 208 | 44 | 6 | int:WDR36 | |
| Interaction | BTF3 interactions | 6.61e-06 | 799 | 44 | 10 | int:BTF3 | |
| Interaction | NPM1 interactions | NELFE DKC1 CCDC80 PUM3 ILF3 RRBP1 MAP1B DDX21 MECP2 TOP1 DHX37 KTN1 | 6.75e-06 | 1201 | 44 | 12 | int:NPM1 |
| Interaction | ERG interactions | 8.53e-06 | 223 | 44 | 6 | int:ERG | |
| Interaction | ADARB1 interactions | 9.33e-06 | 489 | 44 | 8 | int:ADARB1 | |
| Interaction | CEBPA interactions | NELFE PUM3 NOP58 ZNF609 CHD7 ILF3 EIF2A MECP2 TOP1 UBTF FRG1 NFRKB | 9.74e-06 | 1245 | 44 | 12 | int:CEBPA |
| Interaction | BRD3 interactions | 1.00e-05 | 494 | 44 | 8 | int:BRD3 | |
| Interaction | UTP14A interactions | 1.02e-05 | 230 | 44 | 6 | int:UTP14A | |
| Interaction | WWP2 interactions | 1.03e-05 | 840 | 44 | 10 | int:WWP2 | |
| Interaction | DHX15 interactions | 1.13e-05 | 502 | 44 | 8 | int:DHX15 | |
| Interaction | HNRNPK interactions | 1.17e-05 | 853 | 44 | 10 | int:HNRNPK | |
| Interaction | MTDH interactions | 1.18e-05 | 505 | 44 | 8 | int:MTDH | |
| Interaction | LMNA interactions | NELFE DKC1 PUM3 NOP58 ILF3 BBX MAP1B DDX21 MECP2 TOP1 UBTF RALBP1 | 1.35e-05 | 1286 | 44 | 12 | int:LMNA |
| Interaction | USP12 interactions | 1.37e-05 | 67 | 44 | 4 | int:USP12 | |
| Interaction | RRP8 interactions | 1.99e-05 | 259 | 44 | 6 | int:RRP8 | |
| Interaction | SRPK2 interactions | 2.01e-05 | 717 | 44 | 9 | int:SRPK2 | |
| Interaction | SMURF1 interactions | 2.02e-05 | 544 | 44 | 8 | int:SMURF1 | |
| Interaction | DDX21 interactions | 2.04e-05 | 718 | 44 | 9 | int:DDX21 | |
| Interaction | RSBN1 interactions | 2.58e-05 | 161 | 44 | 5 | int:RSBN1 | |
| Interaction | SIRT7 interactions | 2.70e-05 | 744 | 44 | 9 | int:SIRT7 | |
| Interaction | SMARCA5 interactions | 2.96e-05 | 415 | 44 | 7 | int:SMARCA5 | |
| Interaction | NSD2 interactions | 2.97e-05 | 278 | 44 | 6 | int:NSD2 | |
| Interaction | NOP2 interactions | 3.01e-05 | 416 | 44 | 7 | int:NOP2 | |
| Interaction | FZR1 interactions | NOP58 ILF3 PHF8 RRBP1 EIF2A MAP1B DDX21 TCOF1 TOP1 DHX37 FRG1 | 3.18e-05 | 1172 | 44 | 11 | int:FZR1 |
| Interaction | ATG3 interactions | 3.21e-05 | 282 | 44 | 6 | int:ATG3 | |
| Interaction | ADAR interactions | 3.48e-05 | 286 | 44 | 6 | int:ADAR | |
| Interaction | RPL13A interactions | 3.64e-05 | 591 | 44 | 8 | int:RPL13A | |
| Interaction | PRPF3 interactions | 3.83e-05 | 291 | 44 | 6 | int:PRPF3 | |
| Interaction | USP36 interactions | 4.00e-05 | 599 | 44 | 8 | int:USP36 | |
| Interaction | CEBPB interactions | NELFE DKC1 NOP58 CHD7 ILF3 RRBP1 EIF2A DDX21 TCOF1 TOP1 UBTF KTN1 | 4.25e-05 | 1443 | 44 | 12 | int:CEBPB |
| Interaction | RPL22 interactions | 4.30e-05 | 440 | 44 | 7 | int:RPL22 | |
| Interaction | EED interactions | DKC1 PUM3 NOP58 CHD7 ILF3 MAP1B FERMT2 DDX21 TCOF1 TOP1 AP3D1 FRG1 | 4.31e-05 | 1445 | 44 | 12 | int:EED |
| Interaction | GRK5 interactions | 4.64e-05 | 182 | 44 | 5 | int:GRK5 | |
| Interaction | DDX56 interactions | 4.89e-05 | 304 | 44 | 6 | int:DDX56 | |
| Interaction | MPHOSPH8 interactions | 5.01e-05 | 93 | 44 | 4 | int:MPHOSPH8 | |
| Interaction | SYNGAP1 interactions | 5.16e-05 | 307 | 44 | 6 | int:SYNGAP1 | |
| Interaction | TAF1D interactions | 5.22e-05 | 94 | 44 | 4 | int:TAF1D | |
| Interaction | MIDN interactions | 5.47e-05 | 626 | 44 | 8 | int:MIDN | |
| Interaction | HNF1B interactions | 5.69e-05 | 190 | 44 | 5 | int:HNF1B | |
| Interaction | CTCF interactions | 5.77e-05 | 461 | 44 | 7 | int:CTCF | |
| Interaction | HNRNPU interactions | 6.14e-05 | 1035 | 44 | 10 | int:HNRNPU | |
| Interaction | SART1 interactions | 6.16e-05 | 317 | 44 | 6 | int:SART1 | |
| Cytoband | 5q32 | 1.97e-05 | 54 | 44 | 3 | 5q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q32 | 6.41e-05 | 80 | 44 | 3 | chr5q32 | |
| Cytoband | 14q22.1 | 3.84e-04 | 30 | 44 | 2 | 14q22.1 | |
| Cytoband | 12q24.31 | 2.71e-03 | 80 | 44 | 2 | 12q24.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q22 | 3.71e-03 | 94 | 44 | 2 | chr14q22 | |
| GeneFamily | INO80 complex |SRCAP complex | 2.23e-04 | 15 | 27 | 2 | 595 | |
| GeneFamily | DNA helicases | 2.88e-04 | 17 | 27 | 2 | 1167 | |
| GeneFamily | PHD finger proteins | 3.20e-04 | 90 | 27 | 3 | 88 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 2.62e-03 | 51 | 27 | 2 | 870 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PUM3 AKAP13 BBX PHF8 PHF20 MAP1B FERMT2 DDX21 MECP2 TOP1 WBP4 | 1.21e-07 | 856 | 44 | 11 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 1.18e-05 | 656 | 44 | 8 | M18979 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 2.45e-05 | 523 | 44 | 7 | M12707 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 2.79e-05 | 534 | 44 | 7 | MM1054 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | 3.57e-05 | 555 | 44 | 7 | M2343 | |
| Coexpression | MILI_PSEUDOPODIA | 7.24e-05 | 48 | 44 | 3 | M17507 | |
| Coexpression | GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP | 7.57e-05 | 134 | 44 | 4 | M455 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 8.04e-05 | 432 | 44 | 6 | M41149 | |
| Coexpression | MILI_PSEUDOPODIA | 8.69e-05 | 51 | 44 | 3 | MM824 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP | 8.74e-05 | 270 | 44 | 5 | M19982 | |
| Coexpression | MANALO_HYPOXIA_DN | 1.26e-04 | 292 | 44 | 5 | M18562 | |
| Coexpression | CSR_EARLY_UP.V1_UP | 1.26e-04 | 153 | 44 | 4 | M2656 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 1.28e-04 | 680 | 44 | 7 | M41089 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 1.32e-04 | 295 | 44 | 5 | M39121 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | 1.52e-04 | 304 | 44 | 5 | M39113 | |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 1.81e-04 | 168 | 44 | 4 | M18811 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 1.89e-04 | 170 | 44 | 4 | M5657 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 2.54e-04 | 761 | 44 | 7 | M11961 | |
| Coexpression | WEI_MYCN_TARGETS_WITH_E_BOX | 3.24e-04 | 792 | 44 | 7 | M12113 | |
| Coexpression | GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP | 3.26e-04 | 196 | 44 | 4 | M5189 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 3.45e-04 | 199 | 44 | 4 | M9255 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 3.52e-04 | 200 | 44 | 4 | M8050 | |
| Coexpression | GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP | 3.52e-04 | 200 | 44 | 4 | M8968 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP | 3.52e-04 | 200 | 44 | 4 | M5192 | |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP | 3.52e-04 | 200 | 44 | 4 | M6555 | |
| Coexpression | GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP | 3.52e-04 | 200 | 44 | 4 | M5220 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP | 3.52e-04 | 200 | 44 | 4 | M6553 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP | 3.52e-04 | 200 | 44 | 4 | M8554 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP | 3.52e-04 | 200 | 44 | 4 | M3957 | |
| Coexpression | GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN | 3.52e-04 | 200 | 44 | 4 | M8833 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 3.82e-04 | 84 | 44 | 3 | M15130 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 4.10e-04 | 86 | 44 | 3 | MM825 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 4.26e-04 | 380 | 44 | 5 | M41703 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 4.34e-04 | 1394 | 44 | 9 | M9585 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | 4.46e-04 | 1399 | 44 | 9 | M535 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | 5.14e-04 | 1129 | 44 | 8 | M42508 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 5.61e-04 | 1144 | 44 | 8 | MM3843 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.67e-06 | 104 | 41 | 5 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.48e-06 | 204 | 41 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.69e-06 | 469 | 41 | 8 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | POLR1F DKC1 RAD51AP1 PUM3 NOP58 CHD7 EIF2A MAP1B DDX21 TCOF1 TOP1 KTN1 | 5.70e-06 | 1347 | 41 | 12 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 6.79e-06 | 532 | 41 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | POLR1F DKC1 RAD51AP1 PUM3 NOP58 BBX PHF20 EIF2A MAP1B TCOF1 TOP1 KTN1 | 6.83e-06 | 1371 | 41 | 12 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | POLR1F DKC1 RAD51AP1 PUM3 NOP58 CHD7 EIF2A DDX21 TCOF1 TOP1 KTN1 | 8.83e-06 | 1164 | 41 | 11 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | RABL6 POLR1F DKC1 RAD51AP1 NOP58 TRPM1 CHD7 PHF20 MAP1B TCOF1 TOP1 KTN1 | 1.29e-05 | 1459 | 41 | 12 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | 1.40e-05 | 991 | 41 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 | 2.94e-05 | 1080 | 41 | 10 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 4.11e-05 | 496 | 41 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | 7.28e-05 | 1202 | 41 | 10 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000 | 9.02e-05 | 764 | 41 | 8 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 9.49e-05 | 124 | 41 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | e10.5_NeuroEpith_MedialEmin_top-relative-expression-ranked_500_4 | 2.80e-04 | 13 | 41 | 2 | Facebase_ST1_e10.5_NeuroEpith_MedialEmin_500_4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_100 | 3.26e-04 | 14 | 41 | 2 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k1_100 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 5.43e-04 | 1257 | 41 | 9 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 6.00e-04 | 201 | 41 | 4 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | CD positive, T.8Nve.Sp.OT1, CD8+ CD45.1+, Spleen, avg-3 | 6.03e-04 | 358 | 41 | 5 | GSM605909_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Mesoderm Day 15-Confounder_removed-fold2.0_adjp0.05 | 6.05e-04 | 1276 | 41 | 9 | PCBC_ratio_MESO-5_vs_MESO-15_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | 6.59e-04 | 779 | 41 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.21e-04 | 91 | 41 | 3 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 8.05e-04 | 806 | 41 | 7 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_100 | 9.49e-04 | 100 | 41 | 3 | Facebase_RNAseq_e10.5_Mandibular Arch_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.02e-03 | 232 | 41 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-10 | 190 | 44 | 7 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-08 | 184 | 44 | 6 | e7b9c69fc77040c5191ad8089697051e2589c30e | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 1.38e-06 | 195 | 44 | 5 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 175 | 44 | 4 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 187 | 44 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-05 | 191 | 44 | 4 | 219e38df321cd41e2d0861ca01ab0d71bbbd4d9b | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 191 | 44 | 4 | 45023854f285ac465f23ea1b33c970e14992e709 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 191 | 44 | 4 | 6890a8e4b4530987a5b044614fcd7e00716a4d66 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-05 | 195 | 44 | 4 | 5cc2731664146fe54efc4cebe30088a933be98e1 | |
| ToppCell | facs-Mammary_Gland|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 195 | 44 | 4 | 21cfcb751e548591fc8724a8329c294da6012e0f | |
| ToppCell | ASK452|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.06e-05 | 195 | 44 | 4 | 7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 4.14e-05 | 196 | 44 | 4 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.22e-05 | 197 | 44 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | CV-Mild-2|CV / Virus stimulation, Condition and Cluster | 4.22e-05 | 197 | 44 | 4 | dc1cfba2ee66c62b53accefbfce3025cd760524a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-05 | 197 | 44 | 4 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | 3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-05 | 198 | 44 | 4 | 7ad7726fc405806b1d7824f58548073ea5e0c70b | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-05 | 198 | 44 | 4 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-05 | 198 | 44 | 4 | ceede961ad9af6a3159db7efaa5087bf38aafc2d | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-05 | 198 | 44 | 4 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.39e-05 | 199 | 44 | 4 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.39e-05 | 199 | 44 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 4.39e-05 | 199 | 44 | 4 | 6f159c1215439ec22374903124085746fa8da333 | |
| ToppCell | CV-Mild-2|Mild / Virus stimulation, Condition and Cluster | 4.39e-05 | 199 | 44 | 4 | d88cc07053a852e6c468538a0a851ffa09f97a0d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-05 | 200 | 44 | 4 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 4.48e-05 | 200 | 44 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c3-LAMP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.48e-04 | 139 | 44 | 3 | bb2b020dda32ddc60ec9952de5b01acee60b5b59 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 141 | 44 | 3 | 091b5b72811db5fca2314f4a79d467566920e257 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 161 | 44 | 3 | 249c2b97cc25de5053f5048ee354615df49b2081 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-04 | 166 | 44 | 3 | 3695407e4638f3c18fbff63daba52baa9256c429 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.16e-04 | 169 | 44 | 3 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.16e-04 | 169 | 44 | 3 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.16e-04 | 169 | 44 | 3 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-04 | 175 | 44 | 3 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 175 | 44 | 3 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.93e-04 | 176 | 44 | 3 | ce85a13e10cf37f5cf38ca8b0bac6701b6d00ffd | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 7.04e-04 | 177 | 44 | 3 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.16e-04 | 178 | 44 | 3 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-04 | 179 | 44 | 3 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.39e-04 | 180 | 44 | 3 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.39e-04 | 180 | 44 | 3 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.39e-04 | 180 | 44 | 3 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.63e-04 | 182 | 44 | 3 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.63e-04 | 182 | 44 | 3 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.63e-04 | 182 | 44 | 3 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-04 | 182 | 44 | 3 | aa113a0d2c1d28bda24cbb1221afd21b5628dc6d | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.63e-04 | 182 | 44 | 3 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-04 | 183 | 44 | 3 | d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-04 | 183 | 44 | 3 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-04 | 183 | 44 | 3 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.75e-04 | 183 | 44 | 3 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.75e-04 | 183 | 44 | 3 | 956ff95aef9c5521b6a3ba7ac6df0aad242c1c35 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-04 | 183 | 44 | 3 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-04 | 183 | 44 | 3 | 877559962b2b073fc2a9f1b64a76e17895e40a97 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.75e-04 | 183 | 44 | 3 | fef51dcf180e6d4e136362c7e140ec5ef372e6d0 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-04 | 184 | 44 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 185 | 44 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 185 | 44 | 3 | eeb6f55a6f79adf80247baa2c4b0df44553557ad | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-04 | 185 | 44 | 3 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-04 | 185 | 44 | 3 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 186 | 44 | 3 | 393f00ea6b434d4c8854dd8070d176579b71cd3b | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.13e-04 | 186 | 44 | 3 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-04 | 186 | 44 | 3 | b3358e0fa6d845c81e94d56c8575f016621d28ff | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.13e-04 | 186 | 44 | 3 | 9c7924875f70420720149287c500b4dfa8d24673 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.13e-04 | 186 | 44 | 3 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 186 | 44 | 3 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 186 | 44 | 3 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.25e-04 | 187 | 44 | 3 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.25e-04 | 187 | 44 | 3 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.25e-04 | 187 | 44 | 3 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.38e-04 | 188 | 44 | 3 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-04 | 188 | 44 | 3 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-04 | 188 | 44 | 3 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-04 | 188 | 44 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 189 | 44 | 3 | b81540e097e95158851e07bfd78640ed6e64c2cf | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 189 | 44 | 3 | 0fda1a3f1e87fadf5309c8267beaa4501983b1dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-04 | 189 | 44 | 3 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-04 | 189 | 44 | 3 | a9864873b19ab3e60acf11f288fa7275badc2e42 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.64e-04 | 190 | 44 | 3 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.64e-04 | 190 | 44 | 3 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.64e-04 | 190 | 44 | 3 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-04 | 191 | 44 | 3 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.77e-04 | 191 | 44 | 3 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.77e-04 | 191 | 44 | 3 | 482db995930346be69072ace2fd78fd453e97fb5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.77e-04 | 191 | 44 | 3 | 2a107e9096eb58b81b3da61547904d85754f6b2f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.77e-04 | 191 | 44 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.77e-04 | 191 | 44 | 3 | d35692c652977500a3c36aa26c347a072b71e441 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-04 | 192 | 44 | 3 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.91e-04 | 192 | 44 | 3 | 02b11233b4da2d85b96498b3c6e22e3a31b3d049 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-04 | 192 | 44 | 3 | fd08ae787e936cfdb1ab8f19b0fd63005b462709 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-04 | 192 | 44 | 3 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 8.91e-04 | 192 | 44 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-04 | 192 | 44 | 3 | bae236c9f1fac77bce28d0a9cf090100d391ff77 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.04e-04 | 193 | 44 | 3 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 9.04e-04 | 193 | 44 | 3 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.04e-04 | 193 | 44 | 3 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 9.04e-04 | 193 | 44 | 3 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.04e-04 | 193 | 44 | 3 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 4.76e-08 | 178 | 44 | 7 | 3998_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 4.95e-08 | 179 | 44 | 7 | 4585_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.18e-08 | 189 | 44 | 7 | 1045_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 7.45e-08 | 190 | 44 | 7 | 4307_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.12e-06 | 177 | 44 | 6 | 985_DN | |
| Drug | AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.85e-06 | 193 | 44 | 6 | 6920_UP | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.91e-06 | 194 | 44 | 6 | 4312_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.41e-05 | 179 | 44 | 5 | 6910_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.82e-05 | 185 | 44 | 5 | 1673_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.97e-05 | 187 | 44 | 5 | 4323_DN | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.97e-05 | 187 | 44 | 5 | 4581_UP | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.04e-05 | 188 | 44 | 5 | 6735_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.12e-05 | 189 | 44 | 5 | 6750_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 3.12e-05 | 189 | 44 | 5 | 6649_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.37e-05 | 192 | 44 | 5 | 4104_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HT_HG-U133A | 3.45e-05 | 193 | 44 | 5 | 4650_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.45e-05 | 193 | 44 | 5 | 1667_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; HL60; HT_HG-U133A | 3.62e-05 | 195 | 44 | 5 | 3119_DN | |
| Drug | BW-B 70C; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 3.62e-05 | 195 | 44 | 5 | 1132_DN | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A | 3.62e-05 | 195 | 44 | 5 | 3135_DN | |
| Drug | monastrol; Down 200; 100uM; MCF7; HG-U133A | 3.71e-05 | 196 | 44 | 5 | 627_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 3.71e-05 | 196 | 44 | 5 | 4844_DN | |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.71e-05 | 196 | 44 | 5 | 2775_DN | |
| Drug | R(+)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 3.81e-05 | 197 | 44 | 5 | 164_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.81e-05 | 197 | 44 | 5 | 4476_DN | |
| Drug | HA-1077 dihydrochloride; Down 200; 10uM; PC3; HG-U133A | 3.90e-05 | 198 | 44 | 5 | 436_DN | |
| Drug | tetraethylenepentamine pentahydrochloride; Up 200; 100uM; HL60; HG-U133A | 3.99e-05 | 199 | 44 | 5 | 412_UP | |
| Drug | borrelidin | 1.99e-04 | 11 | 44 | 2 | ctd:C005066 | |
| Drug | DB08184 | 3.02e-04 | 167 | 44 | 4 | CID009547945 | |
| Drug | toyocamycin | 3.27e-04 | 14 | 44 | 2 | CID000011824 | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; HL60; HT_HG-U133A | 3.84e-04 | 178 | 44 | 4 | 2977_DN | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; HL60; HG-U133A | 3.92e-04 | 179 | 44 | 4 | 1398_DN | |
| Drug | Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; HL60; HG-U133A | 4.09e-04 | 181 | 44 | 4 | 2007_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.18e-04 | 182 | 44 | 4 | 5802_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 4.26e-04 | 183 | 44 | 4 | 7498_DN | |
| Drug | Ethacrynic acid [58-54-8]; Down 200; 13.2uM; HL60; HG-U133A | 4.35e-04 | 184 | 44 | 4 | 1565_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.63e-04 | 187 | 44 | 4 | 4302_DN | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; HL60; HG-U133A | 4.72e-04 | 188 | 44 | 4 | 1622_DN | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 4.72e-04 | 188 | 44 | 4 | 1177_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 4.72e-04 | 188 | 44 | 4 | 4310_DN | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A | 4.91e-04 | 190 | 44 | 4 | 5080_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; HL60; HT_HG-U133A | 5.01e-04 | 191 | 44 | 4 | 6149_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 5.01e-04 | 191 | 44 | 4 | 4303_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 5.01e-04 | 191 | 44 | 4 | 3926_DN | |
| Drug | retinoic acid; Up 200; 1uM; PC3; HT_HG-U133A | 5.01e-04 | 191 | 44 | 4 | 1211_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 5.01e-04 | 191 | 44 | 4 | 6644_DN | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 5.01e-04 | 191 | 44 | 4 | 7376_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; ssMCF7; HG-U133A | 5.01e-04 | 191 | 44 | 4 | 497_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 5.11e-04 | 192 | 44 | 4 | 1153_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A_EA | 5.11e-04 | 192 | 44 | 4 | 1047_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 5.21e-04 | 193 | 44 | 4 | 2370_DN | |
| Drug | Pivampicillin [33817-20-8]; Down 200; 8.6uM; PC3; HT_HG-U133A | 5.21e-04 | 193 | 44 | 4 | 5046_DN | |
| Drug | staurosporine; Up 200; 0.01uM; MCF7; HG-U133A | 5.21e-04 | 193 | 44 | 4 | 425_UP | |
| Drug | Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A | 5.21e-04 | 193 | 44 | 4 | 6704_DN | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 5.21e-04 | 193 | 44 | 4 | 4305_DN | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A | 5.21e-04 | 193 | 44 | 4 | 6751_DN | |
| Drug | Lynestrenol [52-76-6]; Up 200; 14uM; PC3; HG-U133A | 5.31e-04 | 194 | 44 | 4 | 1953_UP | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HG-U133A | 5.31e-04 | 194 | 44 | 4 | 1924_DN | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A | 5.31e-04 | 194 | 44 | 4 | 4838_UP | |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 5.31e-04 | 194 | 44 | 4 | 4531_UP | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 5.31e-04 | 194 | 44 | 4 | 2009_DN | |
| Drug | Fenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 7432_DN | |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 4577_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 2355_DN | |
| Drug | Clopamide [636-54-4]; Down 200; 11.6uM; HL60; HG-U133A | 5.42e-04 | 195 | 44 | 4 | 1605_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 2071_DN | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 1649_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 2173_DN | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 6828_DN | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 4784_DN | |
| Drug | Betazole hydrochloride; Down 200; 27uM; HL60; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 1854_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 1182_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 7128_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; HL60; HG-U133A | 5.52e-04 | 196 | 44 | 4 | 1440_UP | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 6994_DN | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 4769_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; PC3; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 3702_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; PC3; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 5828_UP | |
| Drug | Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; HL60; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 1872_UP | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 1511_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HG-U133A | 5.52e-04 | 196 | 44 | 4 | 1961_UP | |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 2764_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 3748_DN | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 1518_DN | |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 7185_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A_EA | 5.63e-04 | 197 | 44 | 4 | 994_DN | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; HL60; HG-U133A | 5.63e-04 | 197 | 44 | 4 | 1977_UP | |
| Drug | Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; PC3; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 5823_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 6941_DN | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 3343_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Up 200; 21.4uM; HL60; HG-U133A | 5.63e-04 | 197 | 44 | 4 | 1602_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; PC3; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 5108_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 3425_DN | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 6758_DN | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 7003_UP | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 6805_DN | |
| Drug | Trioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 6216_DN | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; HL60; HG-U133A | 5.63e-04 | 197 | 44 | 4 | 1392_DN | |
| Drug | Lovastatin [75330-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 2854_DN | |
| Drug | 3-hydroxy-(D/L)-kynurenine; Up 200; 9.2uM; MCF7; HT_HG-U133A_EA | 5.63e-04 | 197 | 44 | 4 | 1109_UP | |
| Disease | tumor necrosis factor ligand superfamily member 18 measurement | 3.25e-05 | 6 | 44 | 2 | EFO_0020795 | |
| Disease | gremlin-1 measurement | 6.05e-05 | 8 | 44 | 2 | EFO_0020421 | |
| Disease | corneal resistance factor | 5.42e-04 | 451 | 44 | 5 | EFO_0010067 | |
| Disease | central corneal thickness | 1.15e-03 | 309 | 44 | 4 | EFO_0005213 | |
| Disease | response to risperidone | 1.48e-03 | 38 | 44 | 2 | GO_0097336 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPEKLKKKKKKSKMD | 446 | Q8WY36 | |
| SLPKKKKPKKLKENK | 46 | Q8TDI0 | |
| KKPKKLKENKCKGKR | 51 | Q8TDI0 | |
| LTKPKEKKEKKKKNK | 2776 | Q12802 | |
| KKKKKRSKAKKDPKE | 641 | Q9P2D1 | |
| EKLEKPEKEKKKKMK | 541 | Q76M96 | |
| MVEKKSKKPKKKEKK | 836 | O14617 | |
| SKKPKKKEKKHKEKE | 841 | O14617 | |
| KKKSPKPKKKKHRKE | 866 | O14617 | |
| KSKVKEIKKKEVKVK | 226 | Q96B01 | |
| KQWKEKKKKKKPIQE | 161 | Q15311 | |
| EGKTPSKEKKKKKKK | 646 | Q3YEC7 | |
| KKPKWDDFKKKKKEL | 106 | Q15397 | |
| GPKKKKFKEEKKLKA | 206 | Q9ULG1 | |
| KFKEEKKLKAKLKKV | 211 | Q9ULG1 | |
| KKKKRGKKKHIKEEP | 486 | Q9Y2X3 | |
| AIASPEKKKKKKKKR | 511 | Q9Y2X3 | |
| KPKKSVVVKKKKFKL | 411 | P51787 | |
| VKKEEKEPKKEIKKL | 721 | P46821 | |
| KVKEKEEKKKKKIKT | 311 | Q6P4R8 | |
| KLKKKKKALLALKKQ | 21 | P18615 | |
| KKKKYKIHGEKTKKP | 31 | Q12766 | |
| KLIPTKTDKKKAEKK | 46 | Q86UP2 | |
| KLVLKGTKTKSKKKK | 11 | Q14331 | |
| KSPSKKKKKIQKKEE | 381 | Q12906 | |
| PEIDKKIKNLKKKLK | 531 | Q9BY44 | |
| LKKPRDPTKKKKKKL | 141 | Q96AC1 | |
| KTKSLRKKKEPIEKK | 91 | Q9NR30 | |
| AAPQLIKKEKKKSKK | 461 | O60832 | |
| KKKTKAPPLSKKEKK | 56 | Q8IY37 | |
| KKEKKPLTKKEKKVL | 66 | Q8IY37 | |
| KKIKKVAKKEKPKAV | 606 | Q8N309 | |
| KKKKKKKHSPKNLLL | 901 | Q9BZA8 | |
| KKFKEFVRVKPKKKK | 531 | Q9BVI0 | |
| LKDKPLKFKKVKKDK | 21 | P51608 | |
| EDGPKKKKDKMLKKK | 1251 | Q2WGJ9 | |
| PKSKKEKKKSDKRKK | 1436 | Q13428 | |
| KPLHKKKKRLAKKEK | 321 | Q8WU08 | |
| QEPEEKKKKKKEKKS | 96 | P29973 | |
| KVEKKKKEKTVEKKG | 56 | Q9P2E9 | |
| KLASSPKDKKKKEKK | 131 | Q9P2E9 | |
| PKDKKKKEKKVAKVE | 136 | Q9P2E9 | |
| TEVPGEDKKKKKKKK | 116 | Q8NEW7 | |
| LTPAKDKKKKDKKKK | 721 | O15014 | |
| KEKKEKKKRKKDPSK | 111 | O75554 | |
| EAAKKPKKKKKKKDP | 221 | Q3B726 | |
| PAKGKKKKKKKKEEE | 581 | Q7Z4N2 | |
| KEKKKKSPKKRKLKE | 181 | Q9NPG3 | |
| PEKLDKKEKKMIKKK | 451 | Q9UL36 | |
| KKKYIKKKPLLKEVE | 926 | Q9UPP1 | |
| LSKKYKELPEKKKMK | 146 | P17480 | |
| GKLKKPKNKDKDKKV | 171 | P11387 |